Home / Health / Glioblastoma Patient Survives Seven Years with Laser Treatment
Glioblastoma Patient Survives Seven Years with Laser Treatment
12 Jul
Summary
- Laser therapy shows promise in managing recurrent glioblastoma.
- Patient marks seven years post-diagnosis, defying typical survival rates.
- Minimally invasive LITT uses MRI-guided lasers to destroy tumor tissue.
A glioblastoma patient, Larry Anderson, has reached a seven-year survival milestone following his 2019 diagnosis, thanks to specialized laser therapy. This aggressive brain cancer typically has a grim prognosis.
Anderson's tumor initially returned in 2022, prompting physicians to use laser interstitial thermal therapy (LITT). This minimally invasive technique employs MRI-guided laser energy delivered through a small incision to target and destroy abnormal tissue with high precision.
While LITT has historically been used for epilepsy, technological advances have broadened its application to delicate brain surgeries, including managing glioblastoma. Currently, it serves as an adjuvant treatment, but ongoing studies are investigating its viability as a primary therapy.
Anderson underwent a second LITT procedure last year. His recent scans are clear, allowing him more time with his family. Patients typically recover quickly, resuming normal activities the day after the procedure.
